233 related articles for article (PubMed ID: 20872616)
1. Hepatotoxicity assay using human hepatocytes trapped in microholes of a microfluidic device.
Yeon JH; Na D; Park JK
Electrophoresis; 2010 Sep; 31(18):3167-74. PubMed ID: 20872616
[TBL] [Abstract][Full Text] [Related]
2. Sensitivities of gel entrapped hepatocytes in hollow fibers to hepatotoxic drug.
Meng Q; Zhang G; Shen C; Qiu H
Toxicol Lett; 2006 Sep; 166(1):19-26. PubMed ID: 16814964
[TBL] [Abstract][Full Text] [Related]
3. A microfluidic 3D hepatocyte chip for drug toxicity testing.
Toh YC; Lim TC; Tai D; Xiao G; van Noort D; Yu H
Lab Chip; 2009 Jul; 9(14):2026-35. PubMed ID: 19568671
[TBL] [Abstract][Full Text] [Related]
4. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing.
Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R
Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088
[TBL] [Abstract][Full Text] [Related]
5. Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells.
Kim DE; Jang MJ; Kim YR; Lee JY; Cho EB; Kim E; Kim Y; Kim MY; Jeong WI; Kim S; Han YM; Lee SH
Toxicology; 2017 Jul; 387():1-9. PubMed ID: 28645575
[TBL] [Abstract][Full Text] [Related]
6. Imitation of drug metabolism in human liver and cytotoxicity assay using a microfluidic device coupled to mass spectrometric detection.
Mao S; Gao D; Liu W; Wei H; Lin JM
Lab Chip; 2012 Jan; 12(1):219-26. PubMed ID: 22094544
[TBL] [Abstract][Full Text] [Related]
7. Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model.
Chang R; Emami K; Wu H; Sun W
Biofabrication; 2010 Dec; 2(4):045004. PubMed ID: 21079286
[TBL] [Abstract][Full Text] [Related]
8. Upgrading HepG2 cells with adenoviral vectors that encode drug-metabolizing enzymes: application for drug hepatotoxicity testing.
Gómez-Lechón MJ; Tolosa L; Donato MT
Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):137-148. PubMed ID: 27671376
[TBL] [Abstract][Full Text] [Related]
9. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.
Ware BR; Berger DR; Khetani SR
Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675
[TBL] [Abstract][Full Text] [Related]
11. Characterization of drug metabolites and cytotoxicity assay simultaneously using an integrated microfluidic device.
Ma B; Zhang G; Qin J; Lin B
Lab Chip; 2009 Jan; 9(2):232-8. PubMed ID: 19107278
[TBL] [Abstract][Full Text] [Related]
12. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins.
Gerets HH; Tilmant K; Gerin B; Chanteux H; Depelchin BO; Dhalluin S; Atienzar FA
Cell Biol Toxicol; 2012 Apr; 28(2):69-87. PubMed ID: 22258563
[TBL] [Abstract][Full Text] [Related]
13. Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening.
Wang Z; Li W; Jing H; Ding M; Fu G; Yuan T; Huang W; Dai M; Tang D; Zeng M; Chen Y; Zhang H; Zhu X; Peng Y; Li Q; Yu WF; Yan HX; Zhai B
Theranostics; 2019; 9(22):6690-6705. PubMed ID: 31588244
[No Abstract] [Full Text] [Related]
14. Long-term and mechanistic evaluation of drug-induced liver injury in Upcyte human hepatocytes.
Tolosa L; Jiménez N; Pelechá M; Castell JV; Gómez-Lechón MJ; Donato MT
Arch Toxicol; 2019 Feb; 93(2):519-532. PubMed ID: 30426164
[TBL] [Abstract][Full Text] [Related]
15. Chip-based liver equivalents for toxicity testing--organotypicalness versus cost-efficient high throughput.
Materne EM; Tonevitsky AG; Marx U
Lab Chip; 2013 Sep; 13(18):3481-95. PubMed ID: 23722971
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity.
Meng Q
Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):733-46. PubMed ID: 20380484
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the use of imaging parameters for the detection of compound-induced hepatotoxicity in 384-well cultures of HepG2 cells and cryopreserved primary human hepatocytes.
Garside H; Marcoe KF; Chesnut-Speelman J; Foster AJ; Muthas D; Kenna JG; Warrior U; Bowes J; Baumgartner J
Toxicol In Vitro; 2014 Mar; 28(2):171-81. PubMed ID: 24189122
[TBL] [Abstract][Full Text] [Related]
18. Competency of different cell models to predict human hepatotoxic drugs.
Gómez-Lechón MJ; Tolosa L; Conde I; Donato MT
Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1553-68. PubMed ID: 25297626
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the Metabolic Pathway of Bosentan and of the Cytotoxicity of Bosentan Metabolites Based on a Quantitative Modeling of Metabolism and Transport in Sandwich-Cultured Human Hepatocytes.
Matsunaga N; Kaneko N; Staub AY; Nakanishi T; Nunoya K; Imawaka H; Tamai I
Drug Metab Dispos; 2016 Jan; 44(1):16-27. PubMed ID: 26502773
[TBL] [Abstract][Full Text] [Related]
20. Chemically induced hepatotoxicity in human stem cell-induced hepatocytes compared with primary hepatocytes and HepG2.
Kang SJ; Lee HM; Park YI; Yi H; Lee H; So B; Song JY; Kang HG
Cell Biol Toxicol; 2016 Oct; 32(5):403-17. PubMed ID: 27287938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
